352 results on '"Roessig, Lothar"'
Search Results
2. Vericiguat and Cardiovascular Outcomes in Heart Failure by Baseline Diabetes Status: Insights From the VICTORIA Trial
3. Framework of the strengths and challenges of clinically integrated trials: An expert panel report
4. Recurrent Hospitalizations and Response to Vericiguat in Heart Failure and Reduced Ejection Fraction
5. Drug development for major chronic health conditions—aligning with growing public health needs: Proceedings from a multistakeholder think tank
6. Electronic health record characterization and outcomes of heart failure with preserved ejection fraction
7. Classification of Heart Failure Events by Severity: Insights From the VICTORIA Trial
8. Abstract 14391: Biomarkers, Proteomics, and Echocardiography Lend Insights into Cardiovascular Death in HFrEF: A VICTORIA Substudy
9. Assessment of Biomarkers of Myocardial injury, Inflammation, and Renal Function in Heart Failure With Reduced Ejection Fraction: The VICTORIA Biomarker Substudy
10. Patient-Reported Frailty and Functional Status in Heart Failure With Preserved Ejection Fraction: Insights From VITALITY-HFpEF
11. Evolution of NT-proBNP During Prerandomization Screening in VICTORIA: Implications for Clinical Outcomes and Efficacy of Vericiguat
12. Background Medical Therapy and Clinical Outcomes From the VICTORIA Trial
13. CODE-EHR best-practice framework for the use of structured electronic health-care records in clinical research
14. Sequential Evaluation of NT-proBNP in Heart Failure: Insights Into Clinical Outcomes and Efficacy of Vericiguat
15. Medical Therapy During Hospitalization for Heart Failure With Reduced Ejection Fraction: The VICTORIA Registry
16. Proteomics Identify Clinical Phenotypes and Predict Functional Outcomes in Heart Failure With Preserved Ejection Fraction: Insights From VITALITY-HFpEF.
17. Clinical Implications of Negatively Adjudicated Heart Failure Events: Data From the VICTORIA Study
18. Population Pharmacokinetics and Pharmacodynamics of Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction
19. Abstract 11574: Relationship Between Baseline Electrocardiographic Parameters and Outcomes in Patients With High-Risk Heart Failure With Reduced Ejection Fraction: Insights From the Vericiguat Global Study in Patients With Heart Failure With Reduced Ejection Fraction (VICTORIA) Trial
20. Reassessing Phase II Heart Failure Clinical Trials
21. Soluble GC stimulators and activators: Past, present and future.
22. N-Terminal Pro-B-Type Natriuretic Peptide and Clinical Outcomes: Vericiguat Heart Failure With Reduced Ejection Fraction Study
23. Vericiguat Improves Aortic Wave Reflection Parameters in a New Preclinical Model of Hypertension
24. Heart Failure Clinical Trials in East and Southeast Asia Understanding the Importance and Defining the Next Steps
25. Designing, Conducting, Monitoring, and Analyzing Data from Pragmatic Randomized Clinical Trials: Proceedings from a Multi-stakeholder Think Tank Meeting
26. Enabling patient-reported outcome measures in clinical trials, exemplified by cardiovascular trials
27. Hemoglobin and Clinical Outcomes in the Vericiguat Global Study in Patients With Heart Failure and Reduced Ejection Fraction (VICTORIA)
28. Designing effective drug and device development programs for hospitalized heart failure: A proposal for pretrial registries
29. Developing Therapies for Heart Failure With Preserved Ejection Fraction Current State and Future Directions
30. Accelerometer vs. other activity measures in heart failure with preserved ejection fraction: the VITALITY‐HFpEF trial.
31. Novel sGC Stimulators and sGC Activators for the Treatment of Heart Failure
32. Using Digital Health Technology to Better Generate Evidence and Deliver Evidence-Based Care
33. A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of the Efficacy and Safety of the Oral Soluble Guanylate Cyclase Stimulator: The VICTORIA Trial
34. Lessons From COVID-19 for Pandemic Preparedness: Proceedings From a Multistakeholder Think Tank
35. Abstract 13829: Index Event, Clinical Outcomes and Response to Vericiguat in the Victoria Trial
36. Psychometric properties of the Japanese version of the Kansas City Cardiomyopathy Questionnaire in Japanese patients with chronic heart failure
37. Patient‐reported outcome measures and patient engagement in heart failure clinical trials: multi‐stakeholder perspectives
38. NT-PROBNP DURING SCREENING IN THE STUDY OF VERICIGUAT IN PARTICIPANTS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION (VICTORIA) TRIAL: INSIGHTS INTO OUTCOMES AND VERICIGUAT
39. Impact of COVID-19 on Heart Failure Clinical Trials
40. Rationale and Design of the VITALITY-HFpEF Trial
41. Relationship between baseline electrocardiographic measurements and outcomes in patients with high‐risk heart failure: Insights from the VerICiguaT Global Study in Subjects with Heart Failure with Reduced Ejection Fraction (VICTORIA) trial.
42. Using Natriuretic Peptides for Selection of Patients in Acute Heart Failure Clinical Trials
43. Acute Hemodynamic Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Diastolic Heart Failure (DILATE-1): A Randomized, Double-Blind, Placebo-Controlled, Single-Dose Study
44. CODE-EHR best practice framework for the use of structured electronic healthcare records in clinical research
45. Effect of vericiguat on left ventricular structure and function in patients with heart failure with reduced ejection fraction: The VICTORIA echocardiographic substudy.
46. CODE-EHR best practice framework for the use of structured electronic healthcare records in clinical research
47. Vericiguat and NT‐proBNP in patients with heart failure with reduced ejection fraction: analyses from the VICTORIA trial
48. CODE-EHR best practice framework for the use of structured electronic healthcare records in clinical research
49. Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes According to Baseline HbA1c and Insulin Use:An Analysis From the FIDELIO-DKD Study
50. CODE-EHR best practice framework for the use of structured electronic healthcare records in clinical research
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.